POLYHYDROBENZ(C,D)INDOL-SULFONAMIDE

POLYHYDROBENZ(C,D)INDOL-SULFONAMIDE

Thrombocyte aggregation-inhibiting polyhydrobenz[c,d]indolesulphonamide of the formula (I) in which R1 is hydrogen, aryl or alkyl, R2 is hydrogen, halogen, alkyl, alkoxy, trifluoromethyl, trifluoromethoxy, hydroxyl, aralkoxy or a group of the formula R3 and R4 each independently is hydrogen, alkyl,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PERZBORN,ELISABETH,-BIOL.DR, LIEB,FOLKER,.DR, FIEDLER,VOLKER,DR, ROSENTRETER,ULRICH,.DR, BOESHAGEN,HORST,.DR, OEDIGER,HERMANN,.DR, NIEWOEHNER,ULRICH,.DR, SEUTER,FRIEDEL,DR
Format: Patent
Sprache:ger
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Thrombocyte aggregation-inhibiting polyhydrobenz[c,d]indolesulphonamide of the formula (I) in which R1 is hydrogen, aryl or alkyl, R2 is hydrogen, halogen, alkyl, alkoxy, trifluoromethyl, trifluoromethoxy, hydroxyl, aralkoxy or a group of the formula R3 and R4 each independently is hydrogen, alkyl, aryl, aralkyl or acyl and X is cyano or carboxyl, and salts thereof. Intermediates therefor of the formula (II) are also new.